AN8068571086 - Common Stock - After market: 49.17 +0.07 (+0.14%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-03-14 | Susquehanna | Reiterate | Positive |
2023-01-30 | Goldman Sachs | Maintains | Buy |
2023-01-30 | HSBC | Maintains | Buy |
2023-01-26 | Barclays | Maintains | Overweight |
2023-01-24 | Citigroup | Maintains | Buy |
2023-01-23 | Susquehanna | Maintains | Positive |
2023-01-19 | Benchmark | Initiate | Buy |
2023-01-12 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
2022-11-18 | Piper Sandler | Maintains | Overweight |
2022-11-08 | RBC Capital | Maintains | Outperform |
2022-11-07 | Morgan Stanley | Maintains | Overweight |
2022-10-26 | Barclays | Maintains | Overweight |
2022-10-26 | Wells Fargo | Maintains | Overweight |
2022-10-25 | Goldman Sachs | Maintains | Buy |
2022-10-24 | RBC Capital | Maintains | Outperform |
2022-10-24 | Susquehanna | Maintains | Positive |
2022-10-24 | Morgan Stanley | Maintains | Overweight |
2022-10-24 | Citigroup | Maintains | Buy |
2022-10-19 | Jefferies | Initiate | Buy |
2022-10-13 | Morgan Stanley | Maintains | Overweight |
2022-07-27 | Benchmark | Upgrade | Hold -> Buy |
2022-07-25 | Barclays | Maintains | Overweight |
2022-07-25 | Cowen & Co. | Maintains | Outperform |
2022-07-13 | Goldman Sachs | Maintains | Buy |
2022-07-13 | Morgan Stanley | Maintains | Overweight |
2022-06-08 | Barclays | Maintains | Overweight |
2022-04-27 | Barclays | Maintains | Overweight |
2022-04-27 | HSBC | Upgrade | Hold -> Buy |
2022-04-25 | Wells Fargo | Maintains | Overweight |
2022-04-11 | Morgan Stanley | Maintains | Overweight |
Find the competitors with the best analyst ratings on the USA